Rottweil Regional Court - Court dismisses vaccine damage claim against Biontech
On Wednesday, the Rottweil Regional Court dismissed a lawsuit for alleged damage caused by a coronavirus vaccination. The plaintiff was a 58-year-old man. He accuses the vaccine manufacturer Biontech of causing almost complete blindness in his right eye as a result of a coronavirus vaccination. The man is demanding 150,000 euros in compensation for pain and suffering from the Mainz-based company and a declaration that he must be compensated for all further damages. However, the 2nd Civil Chamber did not consider the requirements for claims to be met, as the Regional Court announced. The plaintiff has one month to appeal against the ruling.
This is not the first case of its kind in Germany. Nor is it the first decision by a court in this context.
Read also:
- Year of climate records: extreme is the new normal
- Precautionary arrests show Islamist terror threat
- Numerous oil, gas and coal lobbyists at climate conference
- COP28: Emirates announce fund for climate projects
- Despite the dismissal of the vaccine damage claim in Rottweil, other similar cases have emerged in Germany, highlighting ongoing concerns about coronavirus vaccinations and their potential side effects.
- The health implications of various diseases, including Covid-19, continue to spark debates worldwide, with individuals and governments seeking proper measures to mitigate their impacts.
- Based in Mainz, Germany, Biontech is a renowned biotech company that has played a significant role in the global fight against Covid-19, developing one of the widely used vaccines against the Coronavirus.
- The ruling by the Regional Court in Rhineland-Palatinate, which shares boundaries with Baden-Württemberg, where Rottweil is located, may set a precedent for future vaccine damage claims against Biontech.
- The picturesque city of Rottweil is not only renowned for its historic charm but has also become a focal point for discussions on vaccine efficacy and safety, with its regional court recently hearing a high-profile case involving Biontech.
- With the Coronavirus still causing widespread concerns, the importance of producing safe and effective vaccines continues to remain a top priority for governments and pharmaceutical companies around the globe.
Source: www.stern.de
